Avantor, Inc. Profit Breakdown
Profit breakdown shows how much each product earned: one column per product, one row per year or quarter. All amounts are the filed figures for that period.
- Avantor, Inc. revenue for the quarter ending 2026-03-31 was $1.58B, a 0.00% change year-over-year.
- Avantor, Inc. revenue for the quarter ending 2025-12-31 was $1.66B, a 1.36% decline year-over-year.
- Avantor, Inc. revenue for the quarter ending 2025-09-30 was $1.62B, a 5.28% decline year-over-year.
- Avantor, Inc. revenue for the quarter ending 2025-06-30 was $1.68B, a 1.14% decline year-over-year.
- Avantor, Inc. revenue for fiscal 2025 was $6.55B, a 3.41% decline from fiscal 2024.
- Avantor, Inc. revenue for fiscal 2024 was $6.78B, a 2.64% decline from fiscal 2023.
- Avantor, Inc. revenue for fiscal 2023 was $6.97B, a 7.26% decline from fiscal 2022.
- Avantor, Inc. revenue for fiscal 2022 was $7.51B, a 1.71% increase from fiscal 2021.
- Available history
- 2017-12-31 to 2026-03-31
- Data captured
Profit by product
Avantor, Inc. did not file profit by product.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |